Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Scott Simonet

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Molecular Genetics and Metabolism|October 3, 2002
Genetics of primary generalized osteoarthritisW Scott Simonet
Nature|May 16, 2003
Osteoclast differentiation and activationWilliam J Boyle, W Scott Simonet, David L Lacey
Nature Reviews. Drug Discovery|May 1, 2012
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabDavid L Lacey, William J Boyle, W Scott Simonet, et al.
Endocrinology|October 26, 2017
Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male OsteoporosisXiaodong Li, Michael S Ominsky, Kelly S Villasenor, et al.
Cell|August 21, 2010
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survivalXiaolan Zhou, Jin Lin Wang, John Lu, et al.
Bone|June 23, 2009
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerinXiaodong Li, Michael S Ominsky, Marina Stolina, et al.
Bone|May 30, 2006
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopeniaJi Li, Ildiko Sarosi, Russell C Cattley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosisXiaodong Li, Michael S Ominsky, Kelly S Warmington, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2008
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strengthXiaodong Li, Michael S Ominsky, Qing-Tian Niu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Genetics and Metabolism|October 3, 2002
Genetics of primary generalized osteoarthritisW Scott Simonet
Nature|May 16, 2003
Osteoclast differentiation and activationWilliam J Boyle, W Scott Simonet, David L Lacey
Nature Reviews. Drug Discovery|May 1, 2012
Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumabDavid L Lacey, William J Boyle, W Scott Simonet, et al.
Endocrinology|October 26, 2017
Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male OsteoporosisXiaodong Li, Michael S Ominsky, Kelly S Villasenor, et al.
Cell|August 21, 2010
Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survivalXiaolan Zhou, Jin Lin Wang, John Lu, et al.
Bone|June 23, 2009
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerinXiaodong Li, Michael S Ominsky, Marina Stolina, et al.
Bone|May 30, 2006
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopeniaJi Li, Ildiko Sarosi, Russell C Cattley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosisXiaodong Li, Michael S Ominsky, Kelly S Warmington, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 14, 2008
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strengthXiaodong Li, Michael S Ominsky, Qing-Tian Niu, et al.
Pageof 2